Under construction – not a live service

Skip to content

Frontlight Research

Trial site

CHU Montpellier

Montpellier, 34295, FranceNot linked to an institution yet

52running trials
28closed trials

The trials here

What the 80 trials at this site are about, from their registry records.

Conditions: Heart failure6 trials
Childhood cancers5 trials
Haemophilia4 trials
Stroke4 trials
Acute myeloid leukaemia3 trials
Depression3 trials
Liver and biliary tract cancer3 trials
Lung cancer3 trials
Mantle cell lymphoma3 trials
ALS (motor neurone disease)2 trials
Aplastic anaemia2 trials
Asthma2 trials
and 36 more
Phase: Phase 29 trials
Phase 37 trials
Phase 11 trial
Phase 1/21 trial
Phase 2/31 trial
Status: Recruiting30 trials
Completed27 trials
Active, not recruiting11 trials
Not yet recruiting11 trials
Terminated1 trial
Lead sponsor: University Hospital, Montpellier16 trials
Assistance Publique - Hôpitaux de Paris6 trials
Assistance Publique Hopitaux De Marseille5 trials
University Hospital, Lille4 trials
CSL Behring3 trials
and 39 more

Running trials

Not yet recruiting
Prognostic and Predictive Factors in Childhood Soft Tissue Sarcomas
NCT07924384· Institut Curie· Source
Contact: Stéphanie HAOUY, MD (principal investigator)
Not yet recruiting
Discontinuation Versus Continuation of Riociguat Monotherapy in Chronic Thromboembolic Pulmonary Hypertension Successfully Treated With Balloon Pulmonary Angioplasty
NCT07644377· Phase 3· Assistance Publique - Hôpitaux de Paris· Source
Contact: Arnaud BOURDIN, PUPH
Recruiting
Efficacy of 12-week Daytime Restricted Eating on Hepatic Steatosis of Obesity
NCT07378072· Nantes University Hospital· Source
Contact: Antoine AVIGNON, MD
Not yet recruiting
Denys-Drash Syndrome and Risk of Post-transplant Lymphoproliferative Disorder
NCT07605884· Assistance Publique - Hôpitaux de Paris· Source
Contact: Mathilde M.D. Grapin
Recruiting
Conceptualizing Borderline Personality Disorder as a Relationship Use Disorder
NCT07337889· University Hospital, Montpellier· Source
Contact: DUCASSE Déborah
Not yet recruiting
FEcal tranSplantation in HidradeniTIs suppuratiVA : a piLot Study
NCT07668713· Phase 1· University Hospital, Clermont-Ferrand· Source
Contact: Céline GIRARD (principal investigator)
Recruiting
Determinants and Consequences of the Transition to Adulthood for Adolescents With Severe Haemophilia: TRANSHEMO 2, an Ancillary Study to the TRANSHEMO Project
NCT07418827· Assistance Publique Hopitaux De Marseille· Source
Contact: Christine BIRON-ANDREANI
Recruiting
Study of Indoor Air Pollutants and Their Impact in Children's Health and Wellbeing
NCT07402200· University Hospital, Montpellier· Source
Contact: Dr CAIMMI, MD
Active, not recruiting
Impact of the Intraoperative Use of Amines in Breast Cancer Surgery on Tumor Recurrence
NCT07624734· University Hospital, Montpellier· Source
Recruiting
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
NCT06793215· Phase 3· Hoffmann-La Roche· Source
Recruiting
Is Non Surgical CaRE Using Treat to Target Multimodal meDIcal Strategies aBLE to Delay or Avoid Total Knee Replacement?
NCT06643845· University Hospital, Brest· Source
Contact: Pers Yves Marie
Recruiting
National Cohort of Subjects at Risk of Developing Rheumatoid Arthritis
NCT06876064· University Hospital, Montpellier· Source
Contact: CLAIRE DAIEN, Professor
Recruiting
ROLL'YN-OMA: an Observational Study in Patients Treated by Omlyclo®, an Omalizumab Biosimilar
NCT07425639· Celltrion HealthCare France· Source
Contact: Arnaud Bourdin, MD, PhD
Recruiting
Acute Reno-Cardiac Action of Dapagliflozin In Advanced Heart Failure Patients on Heart Transplant Waiting List
NCT06868797· Central Hospital, Nancy, France· Source
Contact: Valentin DUPASQUIER, MD-PhD
Recruiting
A Study of Duvelisib Versus Gemcitabine or Bendamustine in Participants With Relapsed/Refractory Nodal T Cell Lymphoma With T Follicular Helper (TFH) Phenotype
NCT06522737· Phase 3· SecuraBio· Source
Contact: Guillaume Cartron (principal investigator)
Recruiting
Target Engagement of EXL01 in the Prevention of Post-operative Recurrence of Crohn's Disease
NCT06925061· Phase 2· Madeleine Bezault· Source
Contact: Pierre Blanc
Recruiting
Indication of HSCT in Patients With Refractory/Relapse AA After First-line Standard Immunosuppressive Therapy Aged More Than 40 Years
NCT06646497· Phase 2· Assistance Publique - Hôpitaux de Paris· Source
Contact: Patrice Ceballos
Active, not recruiting
Link Between Reduction of Suicide Ideation by Esketamine in Add-On and Initial Levels of Psychological Pain and Anhedonia
NCT07199179· University Hospital, Montpellier· Source
Recruiting
Self-Identification Program
NCT06183359· University Hospital, Montpellier· Source
Contact: Déborah Ducasse, MD
Recruiting
Cardiac Amyloidosis pRevaleNce of in OLDer Subjects Affected by Heart Failure
NCT06427304· Gérond'if· Source
Contact: Hubert BLAIN, MD, PHD
Active, not recruiting
Minimal Residual Disease-based Strategy With T-Cell Redirector After Treatment With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (D-VRd) in Newly Diagnosed Multiple Myeloma
NCT06353022· Phase 2· Nantes University Hospital· Source
Recruiting
National Registry of Surgical Treatment and Percutaneous Cryoablation of Parietal Endometriosis
NCT06356831· Centre Hospitalier Intercommunal Creteil· Source
Contact: Cécile VERHEYDEN, Dr
Recruiting
Phase III Study Comparing GVHD Prophylaxis With ATG-thymoglobulin to ATLG-grafalon in Elderly Patients With Acute Myeloid Leukemia or Myelodysplasic Syndrome and Receiving an Allogeneic Hematopoietic Stem Cell Transplantation With a 10/10 HLA Matched Unrelated Donor
NCT06083129· Phase 3· Assistance Publique - Hôpitaux de Paris· Source
Contact: Patrice Ceballos
Recruiting
Screening for Neurodevelopmental Disorders in Siblings of Children With Autism Diagnosed in Tertiary Centers
NCT05512637· University Hospital, Montpellier· Source
Contact: Cécile MICHELON
Recruiting
Study Comparing the Efficacy of 2 RIC Regimens (Clofarabine vs Fludarabine) in Adults With AML Eligible to Allo-SCT
NCT05917405· Phase 2· Nantes University Hospital· Source
Contact: Patrice CEBALLOS, Dr
Recruiting
Aspirin for the Prevention of Preeclampsia and Pregnancy Outcomes After Assisted Reproductive Technology
NCT05625724· Phase 3· University Hospital, Toulouse· Source
Contact: Noémie Ranisavljevic, MD
Active, not recruiting
ALS Diagnosis From a Saliva Sample: a Non-coding RNA Analysis Approach
NCT05928416· ZIWIG· Source
Recruiting
Liver Cancer and Immunotherapy in the Liquid Biopsy Era
NCT05810402· University Hospital, Montpellier· Source
Contact: Thomas BARDOL, M.D.
Recruiting
Acute Myeloid Leukemia At Initial Diagnosis and/or Relapse in Children, Teenagers and Young Adults: Molecular Profiling, Multidrug Testing and MSC Interaction Studies
NCT05772559· Assistance Publique - Hôpitaux de Paris· Source
Contact: Stéphanie Haouy, MD
Active, not recruiting
Regorafenib With Low-dose Chemotherapies and Aspirin Followed by Standard Chemotherapies in Metastatic Colorectal Cancer
NCT05462613· Phase 2/3· Centre Hospitalier Universitaire de Besancon· Source
Active, not recruiting
An Early Access Study of Ivosidenib in Patients With a Pretreated Locally Advanced or Metastatic Cholangiocarcinoma
NCT05876754· Phase 3· Servier Affaires Médicales· Source
Recruiting
Platform for the Prospective Mother-child Study of the Determinants of Neurodevelopmental Disorders
NCT05681923· University Hospital, Montpellier· Source
Contact: Amaria BAGHDADLI
Recruiting
A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.
NCT05689151· Pfizer· Source
Recruiting
Basal Plasma Lithium Levels and Suicidal Events
NCT05409794· University Hospital, Montpellier· Source
Contact: Benedicte NOBILE
Recruiting
Ovarian Reserve and Semen Parameters Evolution During Adjuvant Therapy in Melanoma
NCT05429138· Assistance Publique Hopitaux De Marseille· Source
Contact: Vanessa Loup
Recruiting
Contact Aspiration Versus Stent Retriever for Recanalisation of Acute Stroke Patients With Basilar Artery Occlusion: The Posterior Circulation ASTER Randomized Trial Protocol
NCT05320263· Hopital Foch· Source
Contact: Vincent COSTALAT
Recruiting
Liquid Biopsy and Pancreas Cancer: Detection of AXL(+) CTCs (CTC-AXL-PANC)
NCT05346536· University Hospital, Montpellier· Source
Contact: Thomas Bardol, MD
Recruiting
Hizentra® in Inflammatory Neuropathies - pHeNIx Study
NCT04672733· CSL Behring· Source
Contact: Trial Registration Coordinator
Recruiting
Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide in Patients With Acquired Refractory Aplastic Anemia or in Relapse After Immunosuppression
NCT05126849· Phase 2· Assistance Publique - Hôpitaux de Paris· Source
Contact: Patrice Ceballos
Active, not recruiting
Observatory of Patients With Haemophilia B Treated by IdElvion®
NCT05086575· CSL Behring· Source
Recruiting
WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment)
NCT04701684· Philips Clinical & Medical Affairs Global· Source
Contact: Vincent Costalat
Recruiting
Creation of a Register of Patients With Neonatal-onset Epileptic Encephalopathy
NCT04802135· Assistance Publique Hopitaux De Marseille· Source
Contact: Agathe Roubertie
Active, not recruiting
International Post Market Surveillance Study of Intracranial Aneurysms Treated With an Endovascular Approach
NCT04572230· Stryker Neurovascular· Source
Recruiting
The AFteR Registry - Follow-up Study to Monitor the Efficacy and Safety of the Occlutech AFR in Heart Failure Patients
NCT04405583· Occlutech International AB· Source
Contact: Gönül Sonmez Utkun
Recruiting
Securing Access to Innovative Molecules in Oncology and Hematology for Children, Adolescents and Young Adults
NCT04477681· Gustave Roussy, Cancer Campus, Grand Paris· Source
Contact: Laure SAUMET, MD
Recruiting
Von Willebrand Factor Point-of-care Testing to Improve Minimally Invasive TAVI Outcomes
NCT03728049· University Hospital, Lille· Source
Contact: Eric Van Belle, MD,PhD
Recruiting
Study of Genetic Determinants in Alcoholic Hepatitis and Establishment of a Multicenter Prospective Cohort of Patients With Alcoholic Liver Disease
NCT04106518· University Hospital, Lille· Source
Contact: Alexandre Louvet, MD,PhD
Active, not recruiting
First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma
NCT03625037· Phase 1/2· Genmab· Source
Active, not recruiting
Observation of Clinical Routine Care for Heart Failure Patients Implanted With BIOTRONIK CRT Devices
NCT03366545· Biotronik SE & Co. KG· Source
Recruiting
Correction of Nonsense Mutations in Cystic Fibrosis
NCT03670472· University Hospital, Lille· Source
Contact: Anne Prévotat, MD

Showing 50 of 52.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

Acute myeloid leukaemia3 recruiting
Childhood cancers3 recruiting
Heart failure3 recruiting
Aplastic anaemia2 recruiting
Asthma2 recruiting
Autism2 recruiting
Bipolar disorder2 recruiting
Depression2 recruiting
Stroke2 recruiting
Amyloidosis1 recruiting
Aortic stenosis1 recruiting
Atopic dermatitis (eczema)1 recruiting
CIDP (chronic inflammatory demyelinating polyneuropathy)1 recruiting
Crohn's disease1 recruiting
Cystic fibrosis1 recruiting
Endometriosis1 recruiting
Epilepsy1 recruiting
Fatty liver disease (MASLD/MASH)1 recruiting
Haemophilia1 recruiting
Hidradenitis suppurativa1 recruiting
High blood pressure1 recruiting
Huntington's disease1 recruiting
Liver and biliary tract cancer1 recruiting
Liver cirrhosis1 recruiting
Lung cancer1 recruiting
Melanoma1 recruiting
Obesity1 recruiting
Osteoarthritis1 recruiting
Ovarian cancer1 recruiting
Pancreatic cancer1 recruiting
Pulmonary arterial hypertension1 recruiting
Rheumatoid arthritis1 recruiting
Sarcoma1 recruiting

Closed trials

Completed
A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) Infection
NCT06615921· Takeda· Source
Completed
Measuring the Concurrent Validity of the Upper Limb Use Ratio With Accelerometers in an Ecological Situation After Stroke.
NCT06509542· University Hospital, Montpellier· Source
Completed
A Real-world Study in Participants With Smoldering Multiple Myeloma
NCT06472778· Janssen-Cilag Ltd.· Source
Completed
Effectiveness of the ARTH-e Application for Exercise Adherence in People With Knee Osteoarthritis : RCT
NCT06359171· University Hospital, Clermont-Ferrand· Source
Completed
Millipede AspiRation for Revascularization in Stroke (MARRS) Study
NCT05714501· Perfuze· Source
Completed
Pulsed Field Ablation vs Cryoablation In Paroxysmal Atrial Fibrillation
NCT05940597· University Hospital, Grenoble· Source
Terminated
Satisfaction of Patients With Amyotrophic Lateral Sclerosis Regarding Home Assisted Teleconsultation
NCT05621213· AGIR à Dom· Source
Completed
Aging With HIV and Neurocognitive Decline, a Follow-up Study
NCT05385588· ANRS, Emerging Infectious Diseases· Source
Completed
Virtual Reality for the Mitigation of Anxiety During Intrathecal Administration in Participants With Spinal Muscular Atrophy
NCT05354414· Biogen· Source
Completed
Objective and Perceived Health Status of Elderly People With Moderate or Severe Haemophilia in France: an Ancillary Study of the FranceCoag Registry
NCT05218772· Assistance Publique Hopitaux De Marseille· Source
Completed
Development of Specific Diagnostic Tools for Cardiac Insufficiency With Preserved Ejection Fraction
NCT04699890· University Hospital, Montpellier· Source
Completed
One Day Implantation Program for Heart Failure Patients Implanted With CRT-P
NCT05142293· Biotronik SE & Co. KG· Source
Completed
m-Rehab OSA : Impact of a Telerehabilitation Program Associated With CPAP on Severity Markers of Obstructive Sleep Apnea Syndrome
NCT05049928· University Hospital, Montpellier· Source
Completed
Risk Stratification of Hepatocarcinogenesis Using a Deep Learning Based Clinical, Biological and Ultrasound Model in High-risk Patients
NCT04802954· IHU Strasbourg· Source
Completed
Outcome Measures and Biomarkers in a Cohort of Spinal Muscular Atrophy Type III/ IV Patients
NCT04690998· Assistance Publique Hopitaux De Marseille· Source
Completed
Multicentric Prospective Study to Screen Inborn Errors of Metabolism in Non-immune Hydrops (NIH) Fetalis by Massively Parallel Sequencing
NCT04308603· Hospices Civils de Lyon· Source
Completed
Treatment by a Bispecific CD3xCD20 Antibody for Relapse/Refractory Lymphomas After CAR T-cells Therapy
NCT04703686· Phase 2· The Lymphoma Academic Research Organisation· Source
Completed
Evaluation of a Modified Anti-Platelet Therapy Associated With Low-dose DES Firehawk in Acute Myocardial Infarction Patients Treated With Complete Revascularization Strategy
NCT04753749· MicroPort CRM· Source
Completed
Complication and Lung Function Impairment Prediction Using Perfusion and CT Air Trapping
NCT03885765· University Hospital, Montpellier· Source
Completed
Study of Osimertinib in Patients with a Lung Cancer with Brain or Leptomeningeal Metastases with EGFR Mutation
NCT04233021· Phase 2· Intergroupe Francophone de Cancerologie Thoracique· Source
Completed
Analyse of Tumour and Constitutional DNA for the Study of the Determinism in Child Neoplasia
NCT04471961· University Hospital, Montpellier· Source
Completed
Impact of Probiotics in HIV-positive Patients With Neurocognitive Disorders
NCT04175223· Centre Hospitalier Universitaire de Nice· Source
Completed
Clinical Prognosis of Patients With Atrial Fibrillation During Radiofrequency Ablation
NCT03564327· Centre Hospitalier Universitaire de Nīmes· Source
Completed
Register of Patients With haEmophilia A tReated With Afstyla®
NCT04675541· CSL Behring· Source
Completed
Evaluation of the Impact of Multiple Sclerosis and Its Treatments on Women Fertility
NCT07164924· University Hospital, Clermont-Ferrand· Source
Completed
Is Caffeine an Environmental Modifier in Huntington's Disease?
NCT03034122· University Hospital, Lille· Source
Completed
Efficacy of Upfront and Maintenance Obinutuzumab in Mantle Cell Lymphoma Treated by DHAP and MRD Driven Maintenance
NCT02896582· Phase 2· The Lymphoma Academic Research Organisation· Source
Completed
R-CHOP + R-HAD vs R-CHOP Followed by Maintenance Lenalidomide + Rituximab vs Rituximab for Older Patients With MCL
NCT01865110· Phase 3· The Lymphoma Academic Research Organisation· Source

Site data: ClinicalTrials.govUpdated 13 Nov 2026

Report an error